Title : Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.

Pub. Date : 2004 Nov

PMID : 15390078






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Remarkably, pharmacological FAS blockade using the mycotoxin cerulenin or the novel small compound C75 completely suppressed the state of Her-2/neu-induced malignant transformation by inhibiting the ability of NIH-3T3/Her-2 cells to grow under either anchorage-independent (i.e., to form colonies in soft agar) or low-serum monolayer conditions. Agar erb-b2 receptor tyrosine kinase 2 Mus musculus